(Q68056017)
Statements
Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: a National Cancer Institute of Canada Clinical Trials Group study (English)
D J Stewart
E A Eisenhauer
J Skillings
K I Pritchard
R Buckman
T VAndenberg
S Verma
S Aitken